Immatics NV News - IMTX

Company Name	Stock Ticker Symbol	Market	Type
Immatics NV	IMTX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.05	-0.49%	10.21	16:17:27

Open Price	Low Price	High Price	Close Price	Prev Close
10.18	10.12	10.53	10.21	10.26

more quote information »

Recent News

Date	Time	Source	Heading
3/21/2024	07:00	GLOBE	Immatics Announces Full Year 2023 Financial Results and..
1/22/2024	12:52	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/19/2024	08:58	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
1/17/2024	20:30	GLOBE	Immatics Announces Pricing of $175 Million Public Offering
1/17/2024	16:11	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
1/17/2024	16:01	GLOBE	Immatics Announces Proposed Public Offering
1/16/2024	04:06	PRNUS	DISCO Pharmaceuticals launches as the surfaceome company..
1/16/2024	03:59	PRNUS	DISCO Pharmaceuticals launches as the surfaceome company..
11/30/2023	04:00	GLOBE	Levicept Appoints Eliot Forster as CEO
11/14/2023	07:00	GLOBE	Immatics Announces Third Quarter 2023 Financial Results and..
11/08/2023	07:30	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/08/2023	07:00	GLOBE	Immatics Reports Interim Clinical Data from ACTengine®..
10/24/2023	07:10	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/24/2023	07:00	GLOBE	Immatics Receives FDA Regenerative Medicine Advanced Therapy..
9/14/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
9/13/2023	17:03	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
9/11/2023	07:00	GLOBE	Moderna and Immatics Announce Strategic Multi-Platform..
9/11/2023	06:33	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/25/2023	16:11	EDGAR2	Form F-3 - Registration statement by foreign private issuers
8/17/2023	07:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/17/2023	07:00	GLOBE	Immatics Announces Second Quarter 2023 Financial Results and..
8/10/2023	07:08	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/10/2023	07:00	GLOBE	Immatics Initiates Phase 1/2 Clinical Trial to Evaluate..
7/24/2023	07:15	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/24/2023	07:00	GLOBE	Immatics Announces $35 Million Equity Investment from..
5/16/2023	07:00	GLOBE	Immatics Announces First Quarter 2023 Financial Results and..
5/02/2023	07:00	GLOBE	Immatics Reports Interim Clinical Data from Ongoing Phase 1b..
5/01/2023	07:00	GLOBE	Immatics Announces First Bristol Myers Squibb Opt-in of..